Stock Analysis: Sanofi

SNY was founded in 1973 and is headquartered in Paris, France.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through its Biopharma segment.

Three key data points gauge SNY (or any dividend paying entity):Those three keys also indicate if any company has made, is making, and will make money. 

(1) Price 

(2) Dividends

(3) Returns

SNY Price

Sanofi’s single share price dropped $7.33 (or 13.4%) from $54.89 to $47.56 this past year, per Thursday’s morning market report.

Nine analysts cover the stock. The median of their one year target estimates predict a $10 jump in price.

However, a review of the past ten years of SNY’s prices shows an average annual increase of $0.725 per year.

SNY Dividends

Sanofi has paid annual dividends since June 2003. The June 2025 declared Annual dividend of $2.20 supports a $2.20 forward annual dividend estimate for next year.

SNY Returns

Putting it all together, a hypothetical annual gross gain of $7.56 per share is predicted by adding the $2.20 forward-looking dividend to a possible SNY $5.36 annual price-gain next year.

A little over $1000 invested at Thursday’s $47.56 share price would buy 21 shares which multiply the $7.56 estimated gross gain to an estimated $158.95 upside for the coming year.

29% of that $159 upside gain could come from the $46.10 annual dividend payout from your $1,000 investment.

And the $46.10 dividend from $1k invested is within $1.46 of the SNY single share price.

(A dividend dogcatcher rule is to only buy initial shares of a stock that pay an annual dividend from $1000 invested that is greater than the cost of a single share.) Wait for SNY price to drop below $46.00

SNY’s $46.10 dividend from $1,000 invested is $1.46 below Thursday’s $47.56 single share price. 

The exact track of SNY’s  future share price and dividend will entirely be determined by market action and company finances.  

Remember the best way to track stock performance and dividend payments is through direct ownership of company shares.